마이크로바이옴 샘플 조제 기술 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 워크플로우별, 용도별, 질병별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Microbiome Sample Preparation Technology Market Growth & Trends:

The global microbiome sample preparation technology market size is expected to reach USD 368.74 million in 2030 and is expected to expand at a CAGR of 6.09% from 2025 to 2030. The rising importance of the microbiome as an area of study for Inflammatory Bowel Disease (IBD) research along with the innovation in genome sequencing techniques are significant contributors to the market growth. Crohn's disease is one of the most common diseases of IBD and surging incidence rates in North America and Western Europe, with approximately 100 to 300 per 100,000 people being affected in both regions, are likely to accelerate the R&D for the same.

A metabolite-based treatment method is highly promising for Dysbiosis, despite its existing limitations. Within coming years, researchers are anticipated to require to incorporate metabolomics characterization of the microbial ecosystem into their standard toolkit, enabling the community to define functional signatures for disease states that have previously only been linked to compositional and metagenomic changes.

Additionally, the development of novel metabolite sensors will eventually allow for the targeted regulation of downstream signaling cascades in circumstances when the host's reaction to the microbiome is excessive. Metabolite-based treatments provide a direct and actionable way to combat the host effects of dysbiosis. The era of metabolite research in microbiome science has already begun, and sustained efforts could lead to the discovery of clinically applicable therapeutics for dysbiosis-related disorders.

Other factors such as the rising penetration of personalized medicine are likely to impact the usage of microbiome sample preparation technology. Various research institutes are conducting studies to understand the gut microbiome and its impact on diet followed by the identification of effective therapeutics. For instance, a study was carried out in 2019 at the Weizmann Institute of Science to develop an algorithm based on machine learning and study glycemic response after consuming similar food. The study concluded that patients displayed different glycemic responses, even when food consumed is the same as microbiome played an important determinant of the blood sugar levels than genetic data.

The COVID-19 pandemic accelerated the use of microbiome sample preparation technology for the research proposed. There have been various studies in progress focusing on the alteration of gut microbiome post-COVID-19 infection. According to studies, the abundance of phyla Firmicutes, Bacteroidetes, and Proteobacteria were observed within patients diagnosed with the virus. Furthermore, fecal metabolomic studies in COVID-19 patients have revealed probable amino acid-related pathways that link gut microbiota to inflammation.

However, the high cost of instruments in this market is anticipated to have adverse effects on the growth rate. Emerging nations with low spending capability on healthcare and sanitation are observed to have a high risk of gastrointestinal disorders. With the potential high risk of infection in the population, low penetration of technology within these regions is likely to act as a market restraint within specific countries.

Microbiome Sample Preparation Technology Market Report Highlights:

• By product, the consumables segment is anticipated to exhibit a high growth rate in the forecast period. This is attributed to the increasing demand for library quantitation and amplification kits for specialized enzymes and reagents that provide efficient processing and low amplification bias
• By workflow, the sample extraction/Isolation segment is estimated to dominate the microbiome sample preparation technology market with a share of 24.08% in 2024. Studying human gut microbial in disease depends on the accuracy of microbial data acquisition through the extraction process
• By application, the DNA sequencing segment is estimated to dominate the microbiome sample preparation technology market with a share of 25.64% in 2024. This is attributed to the increasing use of amplicon-based next-generation sequencing for marker genes, an important application in rapid pathogen identification
• By disease type, the gastrointestinal disorders segment dominated the market in 2024, with a share of 53.96%. . Microbiome analysis allows clinicians to identify specific unknown pathogens and track the microbiota and microbiome in regards to illness status and treatment
• By end-use, diagnostic labs segment dominated the market in 2024, with a share of 62.01% due to the launch of various projects and consistent research activities and clinical trials to understand the role of the gut microbiome in the diagnosis of various chronic diseases
• North America dominated the market in 2024 owing to a great performance by key players and rising demand for consumables for downstream applications
• The Asia Pacific is predicted to grow at a significant rate throughout the forecast period due to continuous efforts by major companies to capitalize on opportunities and expand their presence in Asian markets

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Segment Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. Workflow Segment
    • 1.1.1.3. Application Segment
    • 1.1.1.4. Disease Segment
    • 1.1.1.5. End Use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. List of Abbreviations
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Advancements in microbiome-based therapeutics
    • 3.2.1.2. Declining cost of sequencing
    • 3.2.1.3. Big Investments for Microbiome Research
    • 3.2.1.4. Rising Penetration Of Artificial Intelligence In Microbiome Diagnostics
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack Of Skilled Technicians
    • 3.2.2.2. High Cost Of Instruments
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Segment Dashboard
• 4.2. Microbiome Sample Preparation Technology Market: Product Movement Analysis
• 4.3. Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.4.2. Workstation
    • 4.4.2.1. Workstation Market, 2018 - 2030 (USD Million)
  • 4.4.3. Extraction System
    • 4.4.3.1. Extraction System Market, 2018 - 2030 (USD Million)
  • 4.4.4. Liquid Handling Instrument
    • 4.4.4.1. Liquid Handling Instrument Market, 2018 - 2030 (USD Million)
  • 4.4.5. Other Sample Preparation Instruments
    • 4.4.5.1. Other Sample Preparation Instruments Market, 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables Market, 2018 - 2030 (USD Million)
  • 4.5.2. Purification/Extraction Kits
    • 4.5.2.1. Purification/Extraction Kits Market, 2018 - 2030 (USD Million)
  • 4.5.3. Library Preparation Kits
    • 4.5.3.1. Library Preparation Kits Market, 2018 - 2030 (USD Million)
    • 4.5.3.2. DNA Library Preparation Kits
      • 4.5.3.2.1. DNA Library Preparation Kits Market, 2018 - 2030 (USD Million)
    • 4.5.3.3. RNA Library Preparation Kits
      • 4.5.3.3.1. RNA Library Preparation Kits Market, 2018 - 2030 (USD Million)
    • 4.5.3.4. Library Quantitation & Amplification kits
      • 4.5.3.4.1. Library Quantitation & Amplification kits Market, 2018 - 2030 (USD Million)
    • 4.5.3.5. Clean-up and Selection Kits
      • 4.5.3.5.1. Clean-up and Selection Kits Market, 2018 - 2030 (USD Million)
    • 4.5.3.6. Microbiome DNA Enrichment
      • 4.5.3.6.1. Microbiome DNA Enrichment Market, 2018 - 2030 (USD Million)
    • 4.5.3.7. Others
      • 4.5.3.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Workflow Business Analysis

• 5.1. Segment Dashboard
• 5.2. Microbiome Sample Preparation Technology Market: Workflow Movement Analysis
• 5.3. Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
• 5.4. Sample Extraction/Isolation
  • 5.4.1. Sample Extraction/Isolation Market, 2018 - 2030 (USD Million)
• 5.5. Library Preparation
  • 5.5.1. Library Preparation Market, 2018 - 2030 (USD Million)
• 5.6. Sample Quantification
  • 5.6.1. Sample Quantification Market, 2018 - 2030 (USD Million)
• 5.7. Fragmentation
  • 5.7.1. Fragmentation Market, 2018 - 2030 (USD Million)
• 5.8. Target Enrichment
  • 5.8.1. Target Enrichment Market, 2018 - 2030 (USD Million)
• 5.9. Quality Control
  • 5.9.1. Quality Control Market, 2018 - 2030 (USD Million)
• 5.10. Pooling
  • 5.10.1. Pooling Market, 2018 - 2030 (USD Million)
• 5.11. Library Quantification
  • 5.11.1. Library Quantification Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Segment Dashboard
• 6.2. Microbiome Sample Preparation Technology Market: Application Movement Analysis
• 6.3. Microbiome Sample Preparation Technology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. DNA Sequencing
  • 6.4.1. DNA Sequencing Market, 2018 - 2030 (USD Million)
• 6.5. RNA Sequencing
  • 6.5.1. RNA Sequencing Market, 2018 - 2030 (USD Million)
• 6.6. Methylation Sequencing
  • 6.6.1. Methylation Sequencing Market, 2018 - 2030 (USD Million)
• 6.7. Single Cell Sequencing
  • 6.7.1. Single Cell Sequencing Market, 2018 - 2030 (USD Million)
• 6.8. Whole-Genome Sequencing
  • 6.8.1. Whole-Genome Sequencing Market, 2018 - 2030 (USD Million)
• 6.9. Metagenomics
  • 6.9.1. Metagenomics Market, 2018 - 2030 (USD Million)
• 6.10. Others
  • 6.10.1. Other Market, 2018 - 2030 (USD Million)

Chapter 7. Disease Business Analysis

• 7.1. Segment Dashboard
• 7.2. Microbiome Sample Preparation Technology Market: Disease Movement Analysis
• 7.3. Microbiome Sample Preparation Technology Market Size & Trend Analysis, By disease, 2018 to 2030 (USD Million)
• 7.4. Gastrointestinal Disorders
  • 7.4.1. Gastrointestinal Disorders Market, 2018 - 2030 (USD Million)
• 7.5. Autoimmune Disorder
  • 7.5.1. Autoimmune Disorder Market, 2018 - 2030 (USD Million)
• 7.6. Cancer
  • 7.6.1. Cancer Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Other Application Market, 2018 - 2030 (USD Million)

Chapter 8. End Use Business Analysis

• 8.1. Segment Dashboard
• 8.2. Microbiome Sample Preparation Technology Market: End Use Movement Analysis
• 8.3. Microbiome Sample Preparation Technology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Diagnostic Labs
  • 8.4.1. Diagnostic Labs Market, 2018 - 2030 (USD Million)
• 8.5. Pharmaceutical & Biotechnology
  • 8.5.1. Pharmaceutical & Biotechnology Market, 2018 - 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Other End use Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

• 9.1. Regional Market Share Analysis, 2024 & 2030
• 9.2. Regional Market Dashboard
• 9.3. North America
  • 9.3.1. North America Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key Country Dynamics
    • 9.3.2.2. Competitive Scenario
    • 9.3.2.3. Regulatory Framework
    • 9.3.2.4. U.S. Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key Country Dynamics
    • 9.3.3.2. Competitive Scenario
    • 9.3.3.3. Regulatory Framework
    • 9.3.3.4. Canada Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key Country Dynamics
    • 9.3.4.2. Competitive Scenario
    • 9.3.4.3. Regulatory Framework
    • 9.3.4.4. Mexico Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. Europe Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.2. UK
    • 9.4.2.1. Key Country Dynamics
    • 9.4.2.2. Competitive Scenario
    • 9.4.2.3. Regulatory Framework
    • 9.4.2.4. UK Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.3. Germany
    • 9.4.3.1. Key Country Dynamics
    • 9.4.3.2. Competitive Scenario
    • 9.4.3.3. Regulatory Framework
    • 9.4.3.4. Germany Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.4. France
    • 9.4.4.1. Key Country Dynamics
    • 9.4.4.2. Competitive Scenario
    • 9.4.4.3. Regulatory Framework
    • 9.4.4.4. France Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.5. Italy
    • 9.4.5.1. Key Country Dynamics
    • 9.4.5.2. Competitive Scenario
    • 9.4.5.3. Regulatory Framework
    • 9.4.5.4. Italy Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.6. Spain
    • 9.4.6.1. Key Country Dynamics
    • 9.4.6.2. Competitive Scenario
    • 9.4.6.3. Regulatory Framework
    • 9.4.6.4. Spain Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.7. Denmark
    • 9.4.7.1. Key Country Dynamics
    • 9.4.7.2. Competitive Scenario
    • 9.4.7.3. Regulatory Framework
    • 9.4.7.4. Denmark Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.8. Sweden
    • 9.4.8.1. Key Country Dynamics
    • 9.4.8.2. Competitive Scenario
    • 9.4.8.3. Regulatory Framework
    • 9.4.8.4. Sweden Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.4.9. Norway
    • 9.4.9.1. Key Country Dynamics
    • 9.4.9.2. Competitive Scenario
    • 9.4.9.3. Regulatory Framework
    • 9.4.9.4. Norway Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Asia Pacific Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.2. Japan
    • 9.5.2.1. Key Country Dynamics
    • 9.5.2.2. Competitive Scenario
    • 9.5.2.3. Regulatory Framework
    • 9.5.2.4. Japan Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key Country Dynamics
    • 9.5.3.2. Competitive Scenario
    • 9.5.3.3. Regulatory Framework
    • 9.5.3.4. China Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.4. India
    • 9.5.4.1. Key Country Dynamics
    • 9.5.4.2. Competitive Scenario
    • 9.5.4.3. Regulatory Framework
    • 9.5.4.4. India Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key Country Dynamics
    • 9.5.5.2. Competitive Scenario
    • 9.5.5.3. Regulatory Framework
    • 9.5.5.4. Australia Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key Country Dynamics
    • 9.5.6.2. Competitive Scenario
    • 9.5.6.3. Regulatory Framework
    • 9.5.6.4. Thailand Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.5.7. South Korea
    • 9.5.7.1. Key Country Dynamics
    • 9.5.7.2. Competitive Scenario
    • 9.5.7.3. Regulatory Framework
    • 9.5.7.4. South Korea Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Latin America Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.6.2. Brazil
    • 9.6.2.1. Key Country Dynamics
    • 9.6.2.2. Competitive Scenario
    • 9.6.2.3. Regulatory Framework
    • 9.6.2.4. Brazil Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.6.3. Argentina
    • 9.6.3.1. Key Country Dynamics
    • 9.6.3.2. Competitive Scenario
    • 9.6.3.3. Regulatory Framework
    • 9.6.3.4. Argentina Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. MEA Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.7.2. South Africa
    • 9.7.2.1. Key Country Dynamics
    • 9.7.2.2. Competitive Scenario
    • 9.7.2.3. Regulatory Framework
    • 9.7.2.4. South Africa Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.7.3. Saudi Arabia
    • 9.7.3.1. Key Country Dynamics
    • 9.7.3.2. Competitive Scenario
    • 9.7.3.3. Regulatory Framework
    • 9.7.3.4. Saudi Arabia Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.7.4. UAE
    • 9.7.4.1. Key Country Dynamics
    • 9.7.4.2. Competitive Scenario
    • 9.7.4.3. Regulatory Framework
    • 9.7.4.4. UAE Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)
  • 9.7.5. Kuwait
    • 9.7.5.1. Key Country Dynamics
    • 9.7.5.2. Competitive Scenario
    • 9.7.5.3. Regulatory Framework
    • 9.7.5.4. Kuwait Microbiome Sample Preparation Technology Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. Company Profiles/Listing
  • 10.4.1. QIAGEN
    • 10.4.1.1. Overview
    • 10.4.1.2. Financial Performance
    • 10.4.1.3. Product Benchmarking
    • 10.4.1.4. Strategic Initiatives
  • 10.4.2. BGI
    • 10.4.2.1. Overview
    • 10.4.2.2. Financial Performance
    • 10.4.2.3. Product Benchmarking
    • 10.4.2.4. Strategic Initiatives
  • 10.4.3. Bio-Rad Laboratories, Inc.
    • 10.4.3.1. Overview
    • 10.4.3.2. Financial Performance
    • 10.4.3.3. Product Benchmarking
    • 10.4.3.4. Strategic Initiatives
  • 10.4.4. Perkin Elmer, Inc.
    • 10.4.4.1. Overview
    • 10.4.4.2. Financial Performance
    • 10.4.4.3. Product Benchmarking
    • 10.4.4.4. Strategic Initiatives
  • 10.4.5. Agilent Technologies Inc.
    • 10.4.5.1. Overview
    • 10.4.5.2. Financial Performance
    • 10.4.5.3. Product Benchmarking
    • 10.4.5.4. Strategic Initiatives
  • 10.4.6. Illumina, Inc.
    • 10.4.6.1. Overview
    • 10.4.6.2. Financial Performance
    • 10.4.6.3. Product Benchmarking
    • 10.4.6.4. Strategic Initiatives
  • 10.4.7. F. Hoffmann-La Roche Ltd.
    • 10.4.7.1. Overview
    • 10.4.7.2. Financial Performance
    • 10.4.7.3. Product Benchmarking
    • 10.4.7.4. Strategic Initiatives
  • 10.4.8. Danaher
    • 10.4.8.1. Overview
    • 10.4.8.2. Financial Performance
    • 10.4.8.3. Product Benchmarking
    • 10.4.8.4. Strategic Initiatives